Komori
MetaReal (6182) · RiskRestated

Business Impact of Outbreaks of Infectious Diseases Such as COVID-19

First written in FY2021-Q1. 6 of 8 entries say "Restated". Latest entry: FY2023-Q3.

8entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q1 – FY2021-Q3MaterialisedFY2021RestatedFY2022-Q3 – FY2023-Q32020: 220202021: 220212022: 320222023: 1
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「Regarding the impact of COVID-19 on the Group, there were no material changes during the cumulative third quarter of the current consolidated fiscal year to the information disclosed in the securities report for the previous consolidated fiscal year.」

    The Group has reconfirmed that there have been no material changes to the previous year's accounting estimates and assumptions concerning the impact of COVID-19.
  2. FY2023-Q2RestatedAnnual report

    「Regarding the impact of COVID-19 on the Group, there were no material changes during the cumulative second quarter of the current consolidated fiscal year to the information disclosed in the securities report for the previous consolidated fiscal year.」

    The Group has reconfirmed that there have been no material changes to the previous year's accounting estimates and assumptions concerning the impact of COVID-19.
  3. FY2023-Q1RestatedAnnual report

    「Regarding the impact of COVID-19 on the Group, there were no material changes during the cumulative first quarter of the current consolidated fiscal year to the information disclosed in the securities report for the previous consolidated fiscal year.」

    The Group has reconfirmed that there have been no material changes to the previous year's accounting estimates and assumptions concerning the impact of COVID-19.
  4. FY2022-Q3RestatedAnnual report

    「There have been no material changes to the assumptions regarding the impact of the spread of COVID-19 disclosed in the notes to the previous fiscal year's securities report.」

    The Group has reconfirmed that there have been no material changes to the assumptions used in accounting estimates concerning the impact of the spread of COVID-19.
  5. FY2021MaterialisedAnnual report

    「In the fiscal year ended February 2021, the HT business providing outsourced work performed by people was significantly affected by the COVID-19 pandemic.」

    The impact of the infectious disease outbreak materialised in the HT business. Revenue from the HT business decreased 35.5% from the previous consolidated fiscal year, while segment profit decreased 49.0%.
  6. FY2021-Q3RestatedAnnual report

    「Outbreaks of a wide range of infectious diseases, including the recent outbreak of respiratory disease caused by the novel coronavirus, may adversely affect the Group's business. The Group is currently working to provide services required amid changes in the external environment, such as remote work and requests to refrain from going out, and has also taken measures to enable its sales organisation to operate remotely in the same manner as before. However, the impact of outbreaks of infectious diseases, including respiratory disease caused by the novel coronavirus, is broad and difficult to predict, and if the situation continues for an extended period, it may affect the Group's operating performance.」

    The possibility of an impact on operating performance from infectious disease outbreaks and the Group's remote service delivery and sales structure have been reconfirmed.
  7. FY2021-Q2RestatedAnnual report

    「The impact of the spread of infectious diseases, including respiratory illnesses caused by the novel coronavirus, is broad and difficult to predict, and could affect the performance of the group if the problem becomes prolonged.」

    The company reaffirmed its assessment that the impact of the infectious-disease outbreak is broad and difficult to predict and could affect performance if it persists.
  8. FY2021-Q1First statedAnnual report

    「Outbreaks of a wide range of infectious diseases, including the recent outbreak of respiratory disease caused by the novel coronavirus first identified in Wuhan, Hubei Province, China, may adversely affect the Group's business.」

    The Group has added as a new risk the possibility that outbreaks of infectious diseases, including COVID-19, could affect operating performance if their broad and difficult-to-predict impact continues for an extended period.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for MetaReal yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Business Impact of Outbreaks of Infectious Diseases Such as COVID-19 | MetaReal Corporation (6182) | Komori